Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 264

1.

Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia.

Marx CE, Lee J, Subramaniam M, Rapisarda A, Bautista DC, Chan E, Kilts JD, Buchanan RW, Wai EP, Verma S, Sim K, Hariram J, Jacob R, Keefe RS, Chong SA.

Psychopharmacology (Berl). 2014 Jul 17. [Epub ahead of print]

PMID:
25030803
[PubMed - as supplied by publisher]
2.

Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale.

Keefe RS, Davis VG, Spagnola NB, Hilt D, Dgetluck N, Ruse S, Patterson TD, Narasimhan M, Harvey PD.

Eur Neuropsychopharmacol. 2014 Jun 28. pii: S0924-977X(14)00177-1. doi: 10.1016/j.euroneuro.2014.06.009. [Epub ahead of print]

PMID:
25028065
[PubMed - as supplied by publisher]
3.

The Brief Assessment of Cognition In Affective Disorders (BAC-A):Performance of patients with bipolar depression and healthy controls.

Keefe RS, Fox KH, Davis VG, Kennel C, Walker TM, Burdick KE, Harvey PD.

J Affect Disord. 2014 Sep;166:86-92. doi: 10.1016/j.jad.2014.05.002. Epub 2014 May 11.

PMID:
25012414
[PubMed - in process]
4.

The longitudinal course of cognitive impairment in schizophrenia: an examination of data from premorbid through posttreatment phases of illness.

Keefe RS.

J Clin Psychiatry. 2014;75 Suppl 2:8-13. doi: 10.4088/JCP.13065su1.02.

PMID:
24919165
[PubMed - in process]
5.

The continuous performance test, identical pairs: norms, reliability and performance in healthy controls and patients with schizophrenia in Singapore.

Rapisarda A, Kraus M, Tan YW, Lam M, Eng GK, Lee J, Subramaniam M, Collinson SL, Chong SA, Keefe RS.

Schizophr Res. 2014 Jul;156(2-3):233-40. doi: 10.1016/j.schres.2014.04.016. Epub 2014 May 10.

PMID:
24819191
[PubMed - in process]
6.

Development of a virtual reality assessment of everyday living skills.

Ruse SA, Davis VG, Atkins AS, Krishnan KR, Fox KH, Harvey PD, Keefe RS.

J Vis Exp. 2014 Apr 23;(86). doi: 10.3791/51405.

PMID:
24798174
[PubMed - in process]
7.

Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis.

Yong E, Barbato M, Penn DL, Keefe RS, Woods SW, Perkins DO, Addington J.

Psychiatry Res. 2014 Aug 15;218(1-2):39-43. doi: 10.1016/j.psychres.2014.04.003. Epub 2014 Apr 12.

PMID:
24755041
[PubMed - in process]
8.

Relationship of low vitamin D status with positive, negative and cognitive symptom domains in people with first-episode schizophrenia.

Graham KA, Keefe RS, Lieberman JA, Calikoglu AS, Lansing KM, Perkins DO.

Early Interv Psychiatry. 2014 Feb 24. doi: 10.1111/eip.12122. [Epub ahead of print]

PMID:
24612563
[PubMed - as supplied by publisher]
9.

Validation of the Persian version of the brief assessment of cognition in schizophrenia in patients with schizophrenia and healthy controls.

Mazhari S, Parvaresh N, Eslami Shahrbabaki M, Sadeghi MM, Nakhaee N, Keefe RS.

Psychiatry Clin Neurosci. 2014 Feb;68(2):160-6. doi: 10.1111/pcn.12107. Epub 2013 Oct 31.

PMID:
24552637
[PubMed - in process]
10.

A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia.

Umbricht D, Keefe RS, Murray S, Lowe DA, Porter R, Garibaldi G, Santarelli L.

Neuropsychopharmacology. 2014 Jun;39(7):1568-77. doi: 10.1038/npp.2014.17. Epub 2014 Jan 27.

PMID:
24549101
[PubMed - in process]
11.

Using climate-FVS to project landscape-level forest carbon stores for 100 years from field and LiDAR measures of initial conditions.

Gálvez FB, Hudak AT, Byrne JC, Crookston NL, Keefe RF.

Carbon Balance Manag. 2014 Feb 4;9(1):1. doi: 10.1186/1750-0680-9-1.

PMID:
24495313
[PubMed]
Free PMC Article
12.

Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder.

Madhoo M, Keefe RS, Roth RM, Sambunaris A, Wu J, Trivedi MH, Anderson CS, Lasser R.

Neuropsychopharmacology. 2014 May;39(6):1388-98. doi: 10.1038/npp.2013.334. Epub 2013 Dec 6.

PMID:
24309905
[PubMed - in process]
13.

A brain-computer interface based cognitive training system for healthy elderly: a randomized control pilot study for usability and preliminary efficacy.

Lee TS, Goh SJ, Quek SY, Phillips R, Guan C, Cheung YB, Feng L, Teng SS, Wang CC, Chin ZY, Zhang H, Ng TP, Lee J, Keefe R, Krishnan KR.

PLoS One. 2013 Nov 18;8(11):e79419. doi: 10.1371/journal.pone.0079419. eCollection 2013.

PMID:
24260218
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The Longitudinal Youth at Risk Study (LYRIKS)--an Asian UHR perspective.

Lee J, Rekhi G, Mitter N, Bong YL, Kraus MS, Lam M, Rapisarda A, Lee TS, Subramaniam M, Chong SA, Keefe RS.

Schizophr Res. 2013 Dec;151(1-3):279-83. doi: 10.1016/j.schres.2013.09.025. Epub 2013 Oct 15.

PMID:
24139196
[PubMed - in process]
15.

Unraveling the relationship between obesity, schizophrenia and cognition.

Rashid NA, Lim J, Lam M, Chong SA, Keefe RS, Lee J.

Schizophr Res. 2013 Dec;151(1-3):107-12. doi: 10.1016/j.schres.2013.09.020. Epub 2013 Oct 8.

PMID:
24119725
[PubMed - in process]
16.

Elevated Antisaccade Error Rate as an Intermediate Phenotype for Psychosis Across Diagnostic Categories.

Reilly JL, Frankovich K, Hill S, Gershon ES, Keefe RS, Keshavan MS, Pearlson GD, Tamminga CA, Sweeney JA.

Schizophr Bull. 2013 Sep 30. [Epub ahead of print]

PMID:
24080895
[PubMed - as supplied by publisher]
17.

Preserved working memory and altered brain activation in persons at risk for psychosis.

Yaakub SN, Dorairaj K, Poh JS, Asplund CL, Krishnan R, Lee J, Keefe RS, Adcock RA, Wood SJ, Chee MW.

Am J Psychiatry. 2013 Nov 1;170(11):1297-307. doi: 10.1176/appi.ajp.2013.12081135.

PMID:
24077560
[PubMed - indexed for MEDLINE]
18.

Microvascular abnormality in schizophrenia as shown by retinal imaging.

Meier MH, Shalev I, Moffitt TE, Kapur S, Keefe RS, Wong TY, Belsky DW, Harrington H, Hogan S, Houts R, Caspi A, Poulton R.

Am J Psychiatry. 2013 Dec 1;170(12):1451-9. doi: 10.1176/appi.ajp.2013.13020234.

PMID:
24030514
[PubMed - indexed for MEDLINE]
19.

Neuropsychological decline in schizophrenia from the premorbid to the postonset period: evidence from a population-representative longitudinal study.

Meier MH, Caspi A, Reichenberg A, Keefe RS, Fisher HL, Harrington H, Houts R, Poulton R, Moffitt TE.

Am J Psychiatry. 2014 Jan 1;171(1):91-101. doi: 10.1176/appi.ajp.2013.12111438.

PMID:
24030246
[PubMed - indexed for MEDLINE]
20.

Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia.

Marder SR, Alphs L, Anghelescu IG, Arango C, Barnes TR, Caers I, Daniel DG, Dunayevich E, Fleischhacker WW, Garibaldi G, Green MF, Harvey PD, Kahn RS, Kane JM, Keefe RS, Kinon B, Leucht S, Lindenmayer JP, Malhotra AK, Stauffer V, Umbricht D, Wesnes K, Kapur S, Rabinowitz J.

Schizophr Res. 2013 Nov;150(2-3):328-33. doi: 10.1016/j.schres.2013.07.058. Epub 2013 Sep 9. Review.

PMID:
24028744
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk